For: | Li MY, Li TT, Li KJ, Zhou C. Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis. World J Clin Cases 2023; 11(5): 1009-1018 [PMID: 36874430 DOI: 10.12998/wjcc.v11.i5.1009] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i5/1009.htm |
Number | Citing Articles |
1 |
Ye Zang, Wei Xu, Yue Qiu, Xiaomeng Jiang, Yu Fan. Presence of diabetes further heightens hepatocellular carcinoma risk in patients with hepatitis B or hepatitis C virus-related cirrhosis: A meta-analysis. Heliyon 2023; 9(8): e18425 doi: 10.1016/j.heliyon.2023.e18425
|
2 |
Jinlong Huo, Yaxuan Xu, Xingqi Chen, Jie Yu, Lijin Zhao. Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations. Frontiers in Endocrinology 2024; 14 doi: 10.3389/fendo.2023.1308561
|
3 |
Xiyu Liu, Xiaohong Wang. The prognosis of patients with co-morbid diabetes and hepatitis B and strategies for improving outcome. The American Journal of the Medical Sciences 2024; doi: 10.1016/j.amjms.2024.12.011
|